marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2023-Q2
hinzugefügt 02.08.2023
Surface Oncology Bilanz 2011-2024 | SURF
Bilanz Jährlich Surface Oncology
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-20.5 M | -23.8 M | -155 M | 16.8 M | -82.9 M | -22.5 M | -10 M | - | - | - | - | - |
Langfristige Schulden |
24.7 M | 26.9 M | 14.8 M | 5.11 M | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
5.79 M | 5.38 M | 5.53 M | 2.96 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 55.8 M | 44 M | 76.9 M | 60.4 M | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
16.3 M | 20 M | 17.7 M | 19.3 M | 27.2 M | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
66.5 M | 71.9 M | 61.4 M | 75 M | 71.2 M | 100 M | 76.6 M | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | 4.92 M | 14.6 M | 9.84 M | 6.78 M | - | - | - | - | - |
Gewinnrücklagen |
-204 M | -141 M | -62.3 M | -122 M | -66.8 M | -73.9 M | -28.6 M | - | - | - | - | - |
Vermögenswerte |
160 M | 191 M | 217 M | 132 M | 174 M | 81.5 M | 98.1 M | - | - | - | - | - |
Zahlungsmittel |
50.9 M | 56 M | 175 M | 46.8 M | 82.9 M | - | - | - | - | - | - | - |
Buchwert |
93.4 M | 119 M | 156 M | 56.7 M | 103 M | -18.8 M | 21.6 M | - | - | - | - | - |
Gesamtes Eigenkapital |
93.4 M | 119 M | 156 M | 56.7 M | 103 M | -67.3 M | -26.9 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Surface Oncology
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | 23.9 M | 24.7 M | 25.3 M | - | 26.7 M | 26.9 M | 27.4 M | 27.9 M | 28.4 M | 29 M | 29 M | 29 M | 29 M | 17 M | 17 M | 17 M | 17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
16.8 M | 61.2 M | 66.5 M | 68.8 M | - | 70.7 M | 71.9 M | 57.4 M | 57.4 M | 55.7 M | 61.4 M | 61.4 M | 61.4 M | 61.4 M | 75 M | 75 M | 75 M | 75 M | 71.2 M | 71.2 M | 71.2 M | 71.2 M | 100 M | 100 M | 100 M | 100 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.92 M | 4.24 M | 4.92 M | 4.92 M | 14.6 M | 15.8 M | 14.4 M | 12.1 M | 9.84 M | - | 9.84 M | 9.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-252 M | -224 M | -204 M | -183 M | - | -135 M | -141 M | -117 M | -96.8 M | -77.8 M | -62.3 M | -62.3 M | -62.3 M | -62.3 M | -122 M | -122 M | -122 M | -122 M | -66.8 M | -66.8 M | -66.8 M | -66.8 M | -73.9 M | -73.9 M | -73.9 M | -73.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
66 M | 137 M | 160 M | 182 M | - | 218 M | 191 M | 189 M | 206 M | 215 M | 217 M | 217 M | 217 M | 217 M | 132 M | 132 M | 132 M | 132 M | 174 M | 174 M | 174 M | 174 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
14.8 M | 29 M | 50.9 M | 65.1 M | - | 65.7 M | 56 M | 60.8 M | 83.3 M | 101 M | 175 M | 175 M | 175 M | 175 M | 46.8 M | 46.8 M | 46.8 M | 46.8 M | 82.9 M | 82.9 M | 82.9 M | 82.9 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 10 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
49.2 M | 75.8 M | 93.4 M | 113 M | - | 147 M | 119 M | 131 M | 148 M | 159 M | 156 M | 156 M | 156 M | 156 M | 56.7 M | 56.7 M | 56.7 M | 56.7 M | 103 M | 103 M | 103 M | 103 M | -18.8 M | -18.8 M | -18.8 M | -18.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
49.2 M | 75.8 M | 93.4 M | 113 M | 126 M | 147 M | 119 M | 131 M | 148 M | 159 M | 156 M | 156 M | 156 M | 156 M | 56.7 M | 56.7 M | 56.7 M | 56.7 M | 103 M | 103 M | 103 M | 103 M | -67.3 M | -67.3 M | -67.3 M | -67.3 M | -26.9 M | - | - | - | -10.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung